Sanofi Pasteur’s Humenza is set to become the fifth swine flu vaccine in Europe after gaining the support of a …
Specialist Swiss pharma company Basilea has announced a doubling of its revenues in 2009, thanks to the launch of its …
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour

